Application of CRISPR/Cas9-Based Genome Editing in Studying the Mechanism of Pandrug Resistance in Klebsiella pneumoniae

Qiaoling Sun,Yu Wang,Ning Dong,Lingwei Shen,Hongwei Zhou,Yanyan Hu,Danxia Gu,Sheng Chen,Rong Zhang,Quanjiang Ji
DOI: https://doi.org/10.1128/aac.00113-19
IF: 5.938
2019-07-01
Antimicrobial Agents and Chemotherapy
Abstract:In this study, a CRISPR/Cas9-mediated genome editing method was used to study the functions of the mgrB , tetA , and ramR genes in mediating colistin and tigecycline resistance in carbapenem-resistant Klebsiella pneumoniae (CRKP). Inactivation of the tetA or ramR gene or the mgrB gene by CRISPR/Cas9 affected bacterial susceptibility to tigecycline or colistin, respectively.
What problem does this paper attempt to address?